Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. Amazon Location Service.

Clinical trial site

Cedars-Sinai Medical Center

Cedars-Sinai Medical Center in Los Angeles, California, United States is listed as a site for 1,588 registered clinical trials, 558 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 1,588
Ongoing 558

This page covers the site record Cedars-Sinai Medical Center in Los Angeles, California, United States: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled. The organization of the same name, Cedars-Sinai Medical Center, also sponsors trials.

Get the Cedars-Sinai Medical Center report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 1,588 trials counted.

  • Phase 1 132 trials
  • Phase 1/2 69 trials
  • Phase 2 337 trials
  • Phase 2/3 43 trials
  • Phase 3 337 trials
  • Phase 4 62 trials
  • Not applicable 380 trials
  • Observational 223 trials
  • Expanded access 5 trials

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 558 trials
  • Completed 726 trials
  • Terminated 223 trials
  • Other 81 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 104

1994: 2 trials (Observational 1, Phase 3 1) 1995: 2 trials (Observational 1, Phase 3 1) 1996: 1 trials (Phase 3 1) 1997: 4 trials (Phase 3 3, Phase 2/3 1) 1998: 6 trials (Phase 3 1, Phase 2 4, Phase 1/2 1) 1999: 6 trials (Observational 2, Phase 3 2, Phase 2 2) 2000: 4 trials (Observational 1, Phase 3 1, Phase 2 1, Phase 1 1) 2001: 14 trials (Observational 2, Not applicable 2, Phase 4 1, Phase 2/3 1, Phase 2 6, Phase 1 2) 2002: 13 trials (Not applicable 1, Phase 3 5, Phase 2/3 1, Phase 2 3, Phase 1/2 2, Phase 1 1) 2003: 16 trials (Observational 4, Not applicable 2, Phase 4 1, Phase 3 4, Phase 2 4, Phase 1/2 1) 2004: 17 trials (Observational 4, Phase 4 1, Phase 3 6, Phase 2/3 1, Phase 2 5) 2005: 19 trials (Observational 2, Not applicable 3, Phase 3 8, Phase 2/3 2, Phase 2 3, Phase 1 1) 2006: 28 trials (Observational 4, Not applicable 4, Phase 4 3, Phase 3 12, Phase 2/3 1, Phase 2 2, Phase 1 2) 2007: 50 trials (Observational 13, Not applicable 3, Phase 4 3, Phase 3 21, Phase 2 6, Phase 1/2 1, Phase 1 3) 2008: 32 trials (Observational 7, Not applicable 3, Phase 4 1, Phase 3 8, Phase 2/3 1, Phase 2 9, Phase 1/2 1, Phase 1 2) 2009: 46 trials (Observational 11, Not applicable 8, Phase 4 2, Phase 3 10, Phase 2/3 1, Phase 2 12, Phase 1 2) 2010: 56 trials (Observational 9, Not applicable 10, Phase 4 3, Phase 3 14, Phase 2/3 1, Phase 2 13, Phase 1/2 5, Phase 1 1) 2011: 48 trials (Observational 3, Not applicable 9, Phase 4 4, Phase 3 15, Phase 2/3 1, Phase 2 7, Phase 1/2 1, Phase 1 8) 2012: 57 trials (Observational 8, Not applicable 13, Phase 4 1, Phase 3 15, Phase 2/3 1, Phase 2 10, Phase 1/2 6, Phase 1 3) 2013: 70 trials (Observational 6, Not applicable 19, Phase 4 5, Phase 3 17, Phase 2/3 2, Phase 2 10, Phase 1/2 4, Phase 1 7) 2014: 70 trials (Observational 10, Not applicable 23, Phase 4 3, Phase 3 12, Phase 2/3 3, Phase 2 10, Phase 1/2 4, Phase 1 5) 2015: 78 trials (Observational 13, Not applicable 20, Phase 4 2, Phase 3 16, Phase 2 14, Phase 1/2 4, Phase 1 9) 2016: 72 trials (Observational 13, Not applicable 18, Phase 4 2, Phase 3 15, Phase 2/3 1, Phase 2 14, Phase 1/2 1, Phase 1 8) 2017: 102 trials (Observational 7, Not applicable 31, Phase 4 3, Phase 3 21, Phase 2 23, Phase 1/2 6, Phase 1 11) 2018: 82 trials (Observational 12, Not applicable 19, Phase 4 4, Phase 3 11, Phase 2/3 1, Phase 2 28, Phase 1 7) 2019: 86 trials (Observational 13, Not applicable 24, Phase 4 4, Phase 3 20, Phase 2/3 3, Phase 2 14, Phase 1/2 5, Phase 1 3) 2020: 104 trials (Observational 19, Not applicable 19, Phase 4 5, Phase 3 12, Phase 2/3 3, Phase 2 29, Phase 1/2 5, Phase 1 12) 2021: 98 trials (Observational 20, Not applicable 18, Phase 4 3, Phase 3 18, Phase 2/3 3, Phase 2 23, Phase 1/2 2, Phase 1 11) 2022: 82 trials (Observational 7, Not applicable 30, Phase 4 2, Phase 3 8, Phase 2/3 5, Phase 2 16, Phase 1/2 5, Phase 1 9) 2023: 92 trials (Observational 10, Not applicable 23, Phase 4 1, Phase 3 16, Phase 2/3 4, Phase 2 21, Phase 1/2 7, Phase 1 10) 2024: 84 trials (Observational 9, Not applicable 22, Phase 4 4, Phase 3 14, Phase 2/3 3, Phase 2 24, Phase 1/2 2, Phase 1 6) 2025: 81 trials (Observational 10, Not applicable 31, Phase 4 1, Phase 3 19, Phase 2/3 3, Phase 2 11, Phase 1/2 4, Phase 1 2)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 52
2025 81
2024 84
2023 92
2022 82
2021 98
2020 104
2019 86
2018 82
2017 102

Showing 10 of 33 years.

Start your 14-day trial Email me all 33 years as a PDF

2026 is partial: trials registered with a 2026 start date so far, not a full year. 8 trials are registered to start in 2027 or later, and not listed here

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Showing 5 of 1,588 trials.

Start your 14-day trial Email me the first 50 trials as a PDF

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Showing 5 of 353 lead sponsors.

Start your 14-day trial Email me the first 50 lead sponsors as a PDF

Conditions studied

The specific conditions of the trials that list this site, most trials first.

Showing 5 of 642 conditions.

Start your 14-day trial Email me the first 50 conditions as a PDF